Clozapine for medication-related pathological gambling in Parkinson disease.
Identifieur interne : 001698 ( PubMed/Corpus ); précédent : 001697; suivant : 001699Clozapine for medication-related pathological gambling in Parkinson disease.
Auteurs : Alessandro Rotondo ; Domenico Bosco ; Massimiliano Plastino ; Arturo Consoli ; Francesca BoscoSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2010.
English descriptors
- KwdEn :
- Adult, Antiparkinson Agents (adverse effects), Benzothiazoles (adverse effects), Clozapine (therapeutic use), Ergolines (adverse effects), Female, Gambling (chemically induced), Gambling (drug therapy), Humans, Male, Middle Aged, Parkinson Disease (drug therapy), Selegiline (adverse effects), Serotonin Antagonists (therapeutic use).
- MESH :
- chemical , adverse effects : Antiparkinson Agents, Benzothiazoles, Ergolines, Selegiline.
- chemical , therapeutic use : Clozapine, Serotonin Antagonists.
- chemically induced : Gambling.
- drug therapy : Gambling, Parkinson Disease.
- Adult, Female, Humans, Male, Middle Aged.
DOI: 10.1002/mds.23177
PubMed: 20669252
Links to Exploration step
pubmed:20669252Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clozapine for medication-related pathological gambling in Parkinson disease.</title>
<author><name sortKey="Rotondo, Alessandro" sort="Rotondo, Alessandro" uniqKey="Rotondo A" first="Alessandro" last="Rotondo">Alessandro Rotondo</name>
</author>
<author><name sortKey="Bosco, Domenico" sort="Bosco, Domenico" uniqKey="Bosco D" first="Domenico" last="Bosco">Domenico Bosco</name>
</author>
<author><name sortKey="Plastino, Massimiliano" sort="Plastino, Massimiliano" uniqKey="Plastino M" first="Massimiliano" last="Plastino">Massimiliano Plastino</name>
</author>
<author><name sortKey="Consoli, Arturo" sort="Consoli, Arturo" uniqKey="Consoli A" first="Arturo" last="Consoli">Arturo Consoli</name>
</author>
<author><name sortKey="Bosco, Francesca" sort="Bosco, Francesca" uniqKey="Bosco F" first="Francesca" last="Bosco">Francesca Bosco</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="doi">10.1002/mds.23177</idno>
<idno type="RBID">pubmed:20669252</idno>
<idno type="pmid">20669252</idno>
<idno type="wicri:Area/PubMed/Corpus">001698</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Clozapine for medication-related pathological gambling in Parkinson disease.</title>
<author><name sortKey="Rotondo, Alessandro" sort="Rotondo, Alessandro" uniqKey="Rotondo A" first="Alessandro" last="Rotondo">Alessandro Rotondo</name>
</author>
<author><name sortKey="Bosco, Domenico" sort="Bosco, Domenico" uniqKey="Bosco D" first="Domenico" last="Bosco">Domenico Bosco</name>
</author>
<author><name sortKey="Plastino, Massimiliano" sort="Plastino, Massimiliano" uniqKey="Plastino M" first="Massimiliano" last="Plastino">Massimiliano Plastino</name>
</author>
<author><name sortKey="Consoli, Arturo" sort="Consoli, Arturo" uniqKey="Consoli A" first="Arturo" last="Consoli">Arturo Consoli</name>
</author>
<author><name sortKey="Bosco, Francesca" sort="Bosco, Francesca" uniqKey="Bosco F" first="Francesca" last="Bosco">Francesca Bosco</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Antiparkinson Agents (adverse effects)</term>
<term>Benzothiazoles (adverse effects)</term>
<term>Clozapine (therapeutic use)</term>
<term>Ergolines (adverse effects)</term>
<term>Female</term>
<term>Gambling (chemically induced)</term>
<term>Gambling (drug therapy)</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Selegiline (adverse effects)</term>
<term>Serotonin Antagonists (therapeutic use)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Benzothiazoles</term>
<term>Ergolines</term>
<term>Selegiline</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Clozapine</term>
<term>Serotonin Antagonists</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Gambling</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Gambling</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">20669252</PMID>
<DateCreated><Year>2010</Year>
<Month>09</Month>
<Day>14</Day>
</DateCreated>
<DateCompleted><Year>2010</Year>
<Month>12</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>25</Volume>
<Issue>12</Issue>
<PubDate><Year>2010</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Clozapine for medication-related pathological gambling in Parkinson disease.</ArticleTitle>
<Pagination><MedlinePgn>1994-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.23177</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rotondo</LastName>
<ForeName>Alessandro</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Bosco</LastName>
<ForeName>Domenico</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Plastino</LastName>
<ForeName>Massimiliano</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Consoli</LastName>
<ForeName>Arturo</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Bosco</LastName>
<ForeName>Francesca</ForeName>
<Initials>F</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D052160">Benzothiazoles</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004873">Ergolines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012702">Serotonin Antagonists</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>14611-51-9</RegistryNumber>
<NameOfSubstance UI="D012642">Selegiline</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>83619PEU5T</RegistryNumber>
<NameOfSubstance UI="C061333">pramipexole</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>J60AR2IKIC</RegistryNumber>
<NameOfSubstance UI="D003024">Clozapine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>LL60K9J05T</RegistryNumber>
<NameOfSubstance UI="C047047">cabergoline</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000978">Antiparkinson Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D052160">Benzothiazoles</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D003024">Clozapine</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004873">Ergolines</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005715">Gambling</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012642">Selegiline</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D012702">Serotonin Antagonists</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2010</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2010</Year>
<Month>12</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1002/mds.23177</ArticleId>
<ArticleId IdType="pubmed">20669252</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001698 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001698 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:20669252 |texte= Clozapine for medication-related pathological gambling in Parkinson disease. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:20669252" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
![]() | This area was generated with Dilib version V0.6.23. | ![]() |